Sign in

CIK 0001652130

  • Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364785571
Phone
+1 857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$417,899
in 3 filings, $395K under 10b5-1 plans

Net −$417,899. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award +9,943 131,192
2026-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +14,204 14,204
2026-01-05 Lebwohl David EVP, Chief Medical Officer Sale −11,903 $9.21 $110K 121,249
2025-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award +43,200 130,866
2025-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +61,714 61,714
2025-01-03 Lebwohl David EVP, Chief Medical Officer Sale −9,557 $12.18 $116K 87,666
2025-01-01 Lebwohl David EVP, Chief Medical Officer Option exercise +3,189 97,223
2025-01-01 Lebwohl David EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −3,189 0
2024-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award +38,701 93,073
2024-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +55,855 55,855
2024-01-03 Lebwohl David EVP, Chief Medical Officer Sale −5,843 $29.46 $172K 54,372
2024-01-01 Lebwohl David EVP, Chief Medical Officer Option exercise +3,187 60,215
2024-01-01 Lebwohl David EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −3,187 3,189
2023-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award +30,674 56,361
2023-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +43,342 43,342
2023-01-04 Lebwohl David EVP, Chief Medical Officer Sale −2,574 $37.21 $96K 25,687
2023-01-01 Lebwohl David EVP, Chief Medical Officer Option exercise +3,187 28,261
2023-01-01 Lebwohl David EVP, Chief Medical Officer Option exercise · Restricted Stock Unit −3,187 6,376
2022-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award · Stock Option (right to buy) +20,203 20,203
2022-03-01 Lebwohl David EVP, Chief Medical Officer Grant or award +13,816 24,738

Page 1 of 3 · 55 trades